Nakamura N, 2018, Ubiquitin system. Int J Mol Sci, 19(4): 1080. https://doi.org/10.3390/ijms19041080 

Hershko A, Heller H, Elias S, et al., 1983, Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem, 258(13): 8206–8214.

Xu P, Duong DM, Seyfried NT, et al., 2009, Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell, 137(1): 133–145. https://doi.org/10.1016/j.cell.2009.01.041

Nijman SM, Luna-Vargas MP, Velds A, et al., 2005, A genomic and functional inventory of deubiquitinating enzymes. Cell, 123(5): 773–786. https://doi.org/10.1016/j.cell.2005.11.007 

Poondla N, Chandrasekaran AP, Kim KS, et al., 2019, Deubiquitinating enzymes as cancer biomarkers: New therapeutic opportunities? BMB Rep, 52(3): 181–189. https://doi.org/10.5483/BMBRep.2019.52.3.048

Pozhidaeva A, Bezsonova I, 2019, USP7: Structure, substrate specificity, and inhibition. DNA Repair (Amst), 76: 30–39. https://doi.org/10.1016/j.dnarep.2019.02.005

Wang S, Juan J, Zhang Z, et al., 2017, Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. Cell Death Dis, 8(9): e3058. https://doi.org/10.1038/cddis.2017.450

Zhang C, Chen Y, Gan X, et al., 2017, SAK-HV decreases the self-ubiquitination of MEKK1 to promote macrophage proliferation via MAPK/ERK and JNK Pathways. Int J Mol Sci, 18(4): 835. https://doi.org/10.3390/ijms18040835 

Lork M, Verhelst K, Beyaert R, 2017, CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: So similar, yet so different. Cell Death Differ, 24(7): 1172–1183. https://doi.org/10.1038/cdd.2017.46

Song MS, Salmena L, Carracedo A, et al., 2008, The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature, 455(7214): 813–817. https://doi.org/10.1038/nature07290

Jacq X, Kemp M, Martin NM, et al., 2013, Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem Biophys, 67(1): 25–43. https://doi.org/10.1007/s12013-013-9635-3 

Mathien S, Déléris P, Soulez M, et al., 2017, Deubiquitinating enzyme USP20 regulates extracellular signal-regulated kinase 3 stability and biological activity. Mol Cell Biol, 37(9): e00432–16. https://doi.org/10.1128/MCB.00432-16

Kim SY, Baek KH, 2019, TGF-β signaling pathway mediated by deubiquitinating enzymes. Cell Mol Life Sci, 76(4): 653–665. https://doi.org/10.1007/s00018-018-2949-y

Sun T, Liu Z, Yang Q, 2020, The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer, 19(1): 146.

Wang Q, Ma S, Song N, et al., 2016, Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. J Clin Invest, 126(6): 2205–2220. https://doi.org/10.1172/JCI85747

Zhan M, Sun X, Liu J, et al., 2017, Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathway. Biochem Biophys Res Commun, 484(2): 429–434. https://doi.org/10.1016/j.bbrc.2017.01.144 

Jin Q, Martinez CA, Arcipowski KM, et al., 2019, USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia. Clin Cancer Res, 25(1): 222–239. https://doi.org/10.1158/1078-0432.CCR-18-1740

Wang M, Zhang Y, Wang T, et al., 2017, The USP7 inhibitor P5091 induces cell death in ovarian cancers with different P53 status. Cell Physiol Biochem, 43(5): 1755–1766. https://doi.org/10.1159/000484062

Zhao GY, Lin ZW, Lu CL, et al., 2015, USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma. Tumour Biol, 36(3): 1721–1729. https://doi.org/10.1007/s13277-014-2773-4

He Y, Wang S, Tong J, et al., 2020, The deubiquitinase USP7 stabilizes maf proteins to promote myeloma cell survival. J Biol Chem, 295(7): 2084–2096. https://doi.org/10.1074/jbc.RA119.010724

Li M, Brooks CL, Kon N, et al., 2004, A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell, 13(6): 879–886. https://doi.org/10.1016/s1097-2765(04)00157-1

Nicklas S, Hillje AL, Okawa S, et al., 2019, A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7  balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification. Cell Death Differ, 26(4): 728–740. https://doi.org/10.1038/s41418-018-0144-1

Zheng N, Chu M, Lin M, et al., 2020, USP7 stabilizes EZH2 and enhances cancer malignant progression. Am J Cancer Res, 10(1): 299–313.

Li M, Chen D, Shiloh A, et al., 2002, Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature, 416(6881): 648–653. https://doi.org/10.1038/nature737

Tavana O, Gu W, 2017, Modulation of the p53/MDM2 interplay by HAUSP inhibitors. J Mol Cell Biol, 9(1): 45–52. https://doi.org/10.1093/jmcb/mjw049

Brooks CL, Li M, Hu M, et al., 2007, The p53--Mdm2-- HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene, 26(51): 7262–7266. https://doi.org/10.1038/sj.onc.1210531

Ma J, Martin JD, Xue Y, et al., 2010, C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site. Arch Biochem Biophys, 503(2): 207–212. https://doi.org/10.1016/j.abb.2010.08.020

Komander D, Clague MJ, Urbé S, 2009, Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol, 10(8): 550–563. https://doi.org/10.1038/nrm2731

Faesen AC, Luna-Vargas MP, Sixma TK, 2012, The role of UBL domains in ubiquitin-specific proteases. Biochem Soc Trans, 40(3): 539–545. https://doi.org/10.1042/BST20120004

Faesen AC, Dirac AM, Shanmugham A, et al., 2011, Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol Cell, 44(1): 147–159. https://doi.org/10.1016/j.molcel.2011.06.034 

Kim RQ, van Dijk WJ, Sixma TK, 2016, Structure of USP7 catalytic domain and three Ubl-domains reveals a connector α-helix with regulatory role. J Struct Biol, 195(1): 11–18. https://doi.org/10.1016/j.jsb.2016.05.005

van der Knaap JA, Kumar BR, Moshkin YM, et al., 2005, GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol Cell, 17(5): 695–707. https://doi.org/10.1016/j.molcel.2005.02.013

Cotto-Rios XM, Békés M, Chapman J, et al., 2012, Deubiquitinases as a signaling target of oxidative stress. Cell Rep, 2(6): 1475–1484. https://doi.org/10.1016/j.celrep.2012.11.011

Hu M, Li P, Li M, et al., 2002, Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell, 111(7): 1041–1054. https://doi.org/10.1016/s0092-8674(02)01199-6

Culig Z, Santer FR, 2014, Androgen receptor signaling in prostate cancer. Cancer Metastasis Rev, 33(2-3): 413–427. https://doi.org/10.1007/s10555-013-9474-0

Swatek KN, Komander D, 2016, Ubiquitin modifications. Cell Res, 26(4): 399–422. https://doi.org/10.1038/cr.2016.39 

Huang YT, Cheng AC, Tang HC, et al., 2021, USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer. Cell Death Dis, 12(10): 880. https://doi.org/10.1038/s41419-021-04176-8

Jiang S, Wang X, He Y, et al., 2021, Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis. Cell Death Dis, 12(5):456. https://doi.org/10.1038/s41419-021-03732-6

Ji L, Lu B, Zamponi R, et al., 2019, USP7 inhibits Wnt/β- catenin signaling through promoting stabilization of Axin. Nat Commun, 10(1): 4184. https://doi.org/10.1038/s41467-019-12143-3

Lee YR, Chen M, Lee JD, et al., 2019, Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science, 364(6441): eaau0159. https://doi.org/10.1126/science.aau0159 

Wang G, Zhuang Z, Shen S, et al., 2022, Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1. Hum Cell, 35(3): 896–908. https://doi.org/10.1007/s13577-022-00681-w 

He YM, Zhou XM, Jiang SY, et al., 2022, TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer. Acta Pharmacol Sin, 43(3): 681–691. https://doi.org/10.1038/s41401-021-00662-z

Trotman LC, Wang X, Alimonti A, et al., 2007, Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell, 128(1): 141–156. https://doi.org/10.1016/j.cell.2006.11.040 

van der Horst A, de Vries-Smits AM, Brenkman AB, et al., 2006, FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol, 8(10): 1064–1073. https://doi.org/10.1038/ncb1469

Qian J, Pentz K, Zhu Q, et al., 2015, USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability. Oncogene, 34(36): 4791–4796. https://doi.org/10.1038/onc.2014.394

Sarkari F, Sanchez-Alcaraz T, Wang S, et al., 2009, EBNA1- mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog, 5(10): e1000624.

Wu HT, Kuo YC, Hung JJ, et al., 2016, K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression. Nat Commun, 7: 13644. https://doi.org/10.1038/ncomms13644

Chen ST, Okada M, Nakato R, et al., 2015, The deubiquitinating enzyme USP7 regulates androgen receptor activity by modulating its binding to chromatin. J Biol Chem, 290(35): 21713–21723. https://doi.org/10.1074/jbc.M114.628255

Liang L, Peng Y, Zhang J, et al., 2019, Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1. Haematologica, 104(11): 2178–2187.

Mitxitorena I, Somma D, Mitchell JP, et al., 2020, The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits. J Biol Chem, 295(33): 11754–11763. https://doi.org/10.1074/jbc.RA120.014113 

Song N, Cao C, Tian S, et al., 2020, USP7 Deubiquitinates and stabilizes SIRT1. Anat Rec (Hoboken), 303(5): 1337–1345. https://doi.org/10.1002/ar.24252

Pan T, Li X, Li Y, et al., 2021, USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4. Cancer Cell Int, 21(1): 508. https://doi.org/10.1186/s12935-021-02208-z

Han Y, Yun CC, 2020, Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity. Faseb J, 34(12): 16476– 16488. https://doi.org/10.1096/fj.202001875R 

Yuan Y, Miao Y, Zeng C, et al., 2020, Small-molecule inhibitors of ubiquitin-specific protease 7 enhance Type-I interferon antiviral efficacy by destabilizing SOCS1. Immunology, 159(3): 309–321. https://doi.org/10.1111/imm.13147

Yan G, Liu N, Tian J, et al., 2021, Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation. J Cell Mol Med, 25(6): 3149–3159. https://doi.org/10.1111/jcmm.16306 

Meulmeester E, Maurice MM, Boutell C, et al., 2005, Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol Cell, 18(5): 565–576. https://doi.org/10.1016/j.molcel.2005.04.024

Palazón-Riquelme P, Worboys JD, Green J, et al., 2018, USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation. EMBO Rep, 19(10): e44766. https://doi.org/10.15252/embr.201744766

Dong X, Xu X, Yang C, et al., 2021, USP7 regulates the proliferation and differentiation of ATDC5 cells through the Sox9-PTHrP-PTH1R axis. Bone, 143: 115714. https://doi.org/10.1016/j.bone.2020.115714

Tavana O, Li D, Dai C, et al., 2016, HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med, 22(10): 1180–1186. https://doi.org/10.1038/nm.4180

Perry M, Biegert M, Kollala SS, et al., 2021, USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. J Biol Chem, 296: 100396. https://doi.org/10.1016/j.jbc.2021.100396

Nguyen LK, Muñoz-García J, Maccario H, et al., 2011, Switches, excitable responses and oscillations in the Ring1B/ Bmi1 ubiquitination system. PLoS Comput Biol, 7(12): e1002317. https://doi.org/10.1371/journal.pcbi.1002317

Shan H, Li X, Xiao X, et al., 2018, USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia. Signal Transduct Target Ther, 3: 29. https://doi.org/10.1038/s41392-018-0028-3

Lecona E, Rodriguez-Acebes S, Specks J, et al., 2016, USP7 is a SUMO deubiquitinase essential for DNA replication. Nat Struct Mol Biol, 23(4): 270–277. https://doi.org/10.1038/nsmb.3185

Giovinazzi S, Sirleto P, Aksenova V, et al., 2014, Usp7 protects genomic stability by regulating Bub3. Oncotarget, 5(11): 3728–3742. https://doi.org/10.18632/oncotarget.1989

Yamaguchi L, Nishiyama A, Misaki T, et al., 2017, Usp7-dependent histone H3 deubiquitylation regulates maintenance of DNA methylation. Sci Rep, 7(1): 55. https://doi.org/10.1038/s41598-017-00136-5 

Han JJW, Ho DV, Kim HM, et al., 2021, The deubiquitinating enzyme USP7 regulates the transcription factor Nrf1 by modulating its stability in response to toxic metal exposure. J Biol Chem, 296: 100732. https://doi.org/10.1016/j.jbc.2021.100732

Dar A, Shibata E, Dutta A, 2013, Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol Cell Biol, 33(16): 3309–3320. https://doi.org/10.1128/MCB.00358-13

Das S, Chandrasekaran AP, Jo KS, et al., 2020, HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response. Biochim Biophys Acta Mol Cell Res, 1867(12): 118835. https://doi.org/10.1016/j.bbamcr.2020.118835

Qing P, Han L, Bin L, et al., 2011, USP7 regulates the stability and function of HLTF through deubiquitination. J Cell Biochem, 112(12): 3856–3862. https://doi.org/10.1002/jcb.23317

Zemp I, Lingner J, 2014, The shelterin component TPP1 is a binding partner and substrate for the deubiquitinating enzyme USP7. J Biol Chem, 289(41): 28595–28606. https://doi.org/10.1074/jbc.M114.596056

Galarreta A, Valledor P, Ubieto-Capella P, et al., 2021, USP7 limits CDK1 activity throughout the cell cycle. Embo J, 40(11): e99692. https://doi.org/10.15252/embj.201899692 

Holowaty MN, Sheng Y, Nguyen T, et al., 2003, Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J Biol Chem, 278(48): 47753–47761. https://doi.org/10.1074/jbc.M307200200

Zhao XB, Ji FY, Li HR, et al., 2020, P22077 inhibits LPS-induced inflammatory response by promoting K48-linked ubiquitination and degradation of TRAF6. Aging (Albany NY), 12(11): 10969–10982. https://doi.org/10.18632/aging.103309

Alonso-de Vega I, Martín Y, Smits VA, 2014, USP7 controls Chk1 protein stability by direct deubiquitination. Cell Cycle, 13(24): 3921–3926. https://doi.org/10.4161/15384101.2014.973324 

Daubeuf S, Singh D, Tan Y, et al., 2009, HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood, 113(14): 3264–3275. https://doi.org/10.1182/blood-2008-07-168203

Spardy N, Covella K, Cha E, et al., 2009, Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Res, 69(17): 7022–7029. https://doi.org/10.1158/0008-5472.CAN-09-0925

Zaman MM, Nomura T, Takagi T, et al., 2013, Ubiquitination-deubiquitination by the TRIM27-USP7 complex regulates tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol, 33(24): 4971–4984. https://doi.org/10.1128/MCB.00465-13

Yoshihara H, Fukushima T, Hakuno F, et al., 2012, Insulin/ insulin-like growth factor (IGF) stimulation abrogates an association between a deubiquitinating enzyme USP7 and insulin receptor substrates (IRSs) followed by proteasomal degradation of IRSs. Biochem Biophys Res Commun, 423(1): 122–127. https://doi.org/10.1016/j.bbrc.2012.05.093

Sarkari F, Wheaton K, La Delfa A, et al., 2013, Ubiquitin-specific protease 7 is a regulator of ubiquitin-conjugating enzyme UbE2E1. J Biol Chem, 288(23): 16975–16985. https://doi.org/10.1074/jbc.M113.469262

Bhattacharya S, Ghosh MK, 2015, HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. Cell Oncol (Dordr), 38(4): 265–277. https://doi.org/10.1007/s13402-015-0228-6

Li N, Zhao Z, Liu P, et al., 2021, Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis. Mol Ther Oncolytics, 20: 583–595. https://doi.org/10.1016/j.omto.2020.12.008

Episkopou H, Diman A, Claude E, et al., 2019, TSPYL5 depletion induces specific death of ALT cells through USP7- dependent proteasomal degradation of POT1. Mol Cell, 75(3): 469–482.e466. https://doi.org/10.1016/j.molcel.2019.05.027 

Felle M, Joppien S, Németh A, et al., 2011, The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res, 39(19): 8355–8365. https://doi.org/10.1093/nar/gkr528

Zhu Q, Ding N, Wei S, et al., 2020, USP7-mediated deubiquitination differentially regulates CSB but not UVSSA upon UV radiation-induced DNA damage. Cell Cycle, 19(1): 124–141. https://doi.org/10.1080/15384101.2019.1695996

Lu X, Zhang Y, Zheng Y, et al., 2021, The miRNA-15b/USP7/ KDM6B axis engages in the initiation of osteoporosis by modulating osteoblast differentiation and autophagy. J Cell Mol Med, 25(4): 2069–2081. https://doi.org/10.1111/jcmm.16139

Lee KW, Cho JG, Kim CM, et al., 2013, Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor γ (PPARγ) stability through its deubiquitinating activity. J Biol Chem, 288(46): 32886–32896. https://doi.org/10.1074/jbc.M113.496331

Salsman J, Jagannathan M, Paladino P, et al., 2012, Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response. J Virol, 86(2): 806–820. https://doi.org/10.1128/JVI.05442-11

Heimbucher T, Hunter T, 2015, The C. elegans ortholog of USP7 controls DAF-16 stability in insulin/IGF-1-like signaling. Worm, 4(4): e1103429. https://doi.org/10.1080/21624054.2015.1103429

Jäger W, Santag S, Weidner-Glunde M, et al., 2012, The ubiquitin-specific protease USP7 modulates the replication of Kaposi’s sarcoma-associated herpesvirus latent episomal DNA. J Virol, 86(12): 6745–6757. https://doi.org/10.1128/JVI.06840-11

Maertens GN, El Messaoudi-Aubert S, Elderkin S, et al., 2010, Ubiquitin-specific proteases 7 and 11 modulate polycomb regulation of the INK4a tumour suppressor. Embo J, 29(15): 2553–2565. https://doi.org/10.1038/emboj.2010.129

Sarasin A, 2012, UVSSA and USP7: New players regulating transcription-coupled nucleotide excision repair in human cells. Genome Med, 4(5): 44. https://doi.org/10.1186/gm343

Frey Y, Franz-Wachtel M, Macek B, et al., 2022, Proteasomal turnover of the RhoGAP tumor suppressor DLC1 is regulated by HECTD1 and USP7. Sci Rep, 12(1): 5036.

Yi L, Cui Y, Xu Q, et al., 2016, Stabilization of LSD1 by deubiquitinating enzyme USP7 promotes glioblastoma cell tumorigenesis and metastasis through suppression of the p53 signaling pathway. Oncol Rep, 36(5): 2935–2945. https://doi.org/10.3892/or.2016.5099

Xiang Q, Ju H, Li Q, et al., 2018, Human herpesvirus 8 interferon regulatory factors 1 and 3 mediate replication and latency activities via interactions with USP7 deubiquitinase. J Virol, 92(7): e02003–17. https://doi.org/10.1128/JVI.02003-17 

Du Z, Song J, Wang Y, et al., 2010, DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci Signal, 3(146): ra80. https://doi.org/10.1126/scisignal.2001462

Bhattacharya S, Ghosh MK, 2014, HAUSP, a novel deubiquitinase for Rb MDM2 the critical regulator. Febs J, 281(13): 3061–3078. https://doi.org/10.1111/febs.12843

Lee HR, Choi WC, Lee S, et al., 2011, Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. Nat Struct Mol Biol, 18(12): 1336–1344. https://doi.org/10.1038/nsmb.2142

Ching W, Koyuncu E, Singh S, et al., 2013, A ubiquitin-specific protease possesses a decisive role for adenovirus replication and oncogene-mediated transformation. PLoS Pathog, 9(3): e1003273. https://doi.org/10.1371/journal.ppat.1003273 

Yang P, Xie J, Li Y, et al., 2020, Deubiquitinase USP7-mediated MCL-1 up-regulation enhances arsenic and benzo(a)pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis. Theranostics, 10(20): 9050–9065. https://doi.org/10.7150/thno.47897 

Huang Q, Qin D, Pei D, et al., 2022, UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. FASEB J, 36(1): e22112. https://doi.org/10.1096/fj.202100974RRR

Wu Y, Gu H, Bao Y, et al., 2022, USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. Cell Biochem Funct, 40(4): 379–390. https://doi.org/10.1002/cbf.3702

Holowaty MN, Zeghouf M, Wu H, et al., 2003, Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J Biol Chem, 278(32): 29987–29994. https://doi.org/10.1074/jbc.M303977200

Meulmeester E, Pereg Y, Shiloh Y, et al., 2005, ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle, 4(9): 1166–1170. https://doi.org/10.4161/cc.4.9.1981

de Bie P, Zaaroor-Regev D, Ciechanover A, 2010, Regulation of the Polycomb protein RING1B ubiquitination by USP7. Biochem Biophys Res Commun, 400(3): 389–395. https://doi.org/10.1016/j.bbrc.2010.08.082

He J, Zhu Q, Wani G, et al., 2014, Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis. J Biol Chem, 289(39): 27278– 27289. https://doi.org/10.1074/jbc.M114.589812

Xia X, Liao Y, Huang C, et al., 2019, Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis. Cancer Lett, 465: 118–128. https://doi.org/10.1016/j.canlet.2019.09.003 

Sun X, Ding Y, Zhan M, et al., 2019, Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie. Nat Commun, 10(1): 411. https://doi.org/10.1038/s41467-019-08334-7

Lee JE, Park CM, Kim JH, 2020, USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells. Genet Mol Biol, 43(2): e20190338. https://doi.org/10.1590/1678-4685-GMB-2019-0338

Khoronenkova SV, Dianov GL, 2013, USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair. Nucleic Acids Res, 41(3): 1750–1756. https://doi.org/10.1093/nar/gks1359

Zhu Q, Sharma N, He J, et al., 2015, USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168. Cell Cycle, 14(9): 1413–1425. https://doi.org/10.1080/15384101.2015.1007785

Ni W, Lin S, Bian S, et al., 2020, USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638. Cell Death Dis, 11(10): 843.

Franqui-Machin R, Hao M, Bai H, et al., 2018, Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. J Clin Invest, 128(7): 2877–2893. https://doi.org/10.1172/JCI98765

Kim JM, Yang YS, Park KH, et al., 2020, A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation. Nat Commun, 11(1): 2289. https://doi.org/10.1038/s41467-020-16038-6

Ma P, Yang X, Kong Q, et al., 2014, The ubiquitin ligase RNF220 enhances canonical Wnt signaling through USP7- mediated deubiquitination of β-catenin. Mol Cell Biol, 34(23): 4355–4366. https://doi.org/10.1128/MCB.00731-14

Jang SY, Jang SW, Ko J, 2012, Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration. Cancer Lett, 314(2): 185–197. https://doi.org/10.1016/j.canlet.2011.09.028

Hofseth LJ, Hussain SP, Harris CC, 2004, p53: 25 years after its discovery. Trends Pharmacol Sci, 25(4): 177–181. https://doi.org/10.1016/j.tips.2004.02.009

Sabapathy K, Lane DP, 2018, Therapeutic targeting of p53: All mutants are equal, but some mutants are more equal than others. Nat Rev Clin Oncol, 15(1): 13–30. https://doi.org/10.1038/nrclinonc.2017.151

Kruse JP, Gu W, 2009, Modes of p53 regulation. Cell, 137(4): 609–622. https://doi.org/10.1016/j.cell.2009.04.050

Momand J, Zambetti GP, Olson DC, et al., 1992, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69(7): 1237–1245. https://doi.org/10.1016/0092-8674(92)90644-r

Hu M, Gu L, Li M, et al., 2006, Structural basis of competitive recognition of p53 and MDM2 by HAUSP/ USP7: Implications for the regulation of the p53-MDM2 pathway. PLoS Biol, 4(2): e27. https://doi.org/10.1371/journal.pbio.0040027

Sheng Y, Saridakis V, Sarkari F, et al., 2006, Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol, 13(3): 285–291. https://doi.org/10.1038/nsmb1067

Cummins JM, Rago C, Kohli M, et al., 2004, Tumour suppression: Disruption of HAUSP gene stabilizes p53. Nature, 428(6982):1 p following 486. https://doi.org/10.1038/nature02501

Ali A, Raja R, Farooqui SR, et al., 2017, USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein. Biochem J, 474(10): 1653–1668. https://doi.org/10.1042/BCJ20160304

Gao L, Zhu D, Wang Q, et al., 2021, Proteome analysis of USP7 substrates revealed its role in melanoma through PI3K/Akt/FOXO and AMPK pathways. Front Oncol, 11: 650165. https://doi.org/10.3389/fonc.2021.650165

Yao Y, Zhang Y, Shi M, et al., 2018, Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma. J Leukoc Biol, 104(6): 1105–1115. https://doi.org/10.1002/JLB.2A1017-420RR

Cai J, Chen HY, Peng SJ, et al., 2018, USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling. Faseb J, 32(10): 5238–5249. https://doi.org/10.1096/fj.201700473RR 

Colleran A, Collins PE, O’Carroll C, et al., 2013, Deubiquitination of NF-κB by ubiquitin-specific protease-7 promotes transcription. Proc Natl Acad Sci U S A, 110(2): 618–623. https://doi.org/10.1073/pnas.1208446110

Zeng M, Zhang X, Xing W, et al., 2022, Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53/p21 pathway. Toxicol Lett, 359: 31–45. https://doi.org/10.1016/j.toxlet.2022.01.017

Duan D, Shang M, Han Y, et al., 2022, EZH2-CCF-cGAS Axis Promotes Breast Cancer Metastasis. Int J Mol Sci, 23(3): 1788. https://doi.org/10.3390/ijms23031788

Qi SM, Cheng G, Cheng XD, et al., 2020, Targeting USP7- mediated deubiquitination of MDM2/MDMX-p53 pathway for cancer therapy: Are we there yet? Front Cell Dev Biol, 8: 233. https://doi.org/10.3389/fcell.2020.00233

Cheng X, Zhang B, Guo F, et al., 2022, Deubiquitination of FBP1 by USP7 blocks FBP1-DNMT1 interaction and decreases the sensitivity of pancreatic cancer cells to PARP inhibitors. Mol Oncol, 16(7): 1591–1607. https://doi.org/10.1002/1878-0261.13149

Zhang T, Periz G, Lu YN, et al., 2020, USP7 regulates ALS-associated proteotoxicity and quality control through the NEDD4L-SMAD pathway. Proc Natl Acad Sci U S A, 117(45): 28114–28125. https://doi.org/10.1073/pnas.2014349117 

Hou R, Li Y, Luo X, et al., 2022, ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis. Int J Biol Sci, 18(6): 2553–2567. https://doi.org/10.7150/ijbs.67476

Tang LJ, Zhou YJ, Xiong XM, et al., 2021, Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53/ TfR1 pathway in the rat hearts after ischemia/reperfusion. Free Radic Biol Med, 162: 339–352. https://doi.org/10.1016/j.freeradbiomed.2020.10.307

Yang X, Jin J, Yang J, et al., 2021, Expression of ubiquitin-specific protease 7 in oral squamous cell carcinoma promotes tumor cell proliferation and invasion. Genet Mol Biol, 44(4): e20210058. https://doi.org/10.1590/1678-4685-GMB-2021-0058

Li T, Guan J, Li S, et al., 2014, HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination. Cell Death Dis, 5(5): e1229. https://doi.org/10.1038/cddis.2014.197

Liu G, Liu Q, Yan B, et al., 2020, USP7 inhibition alleviates H(2)O(2)-induced injury in chondrocytes via inhibiting NOX4/NLRP3 pathway. Front Pharmacol, 11: 617270. https://doi.org/10.3389/fphar.2020.617270

Forand A, Koumakis E, Rousseau A, et al., 2016, Disruption of the phosphate transporter Pit1 in hepatocytes improves glucose metabolism and insulin signaling by modulating the USP7/IRS1 interaction. Cell Rep, 16(10): 2736–2748. https://doi.org/10.1016/j.celrep.2016.08.012

Li Q, Sun H, Luo D, et al., 2021, Lnc-RP11-536 K7.3/SOX2/ HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids. J Exp Clin Cancer Res, 40(1): 348. https://doi.org/10.1186/s13046-021-02143-x

Zhou Z, Yao X, Li S, et al., 2015, Deubiquitination of Ci/ Gli by Usp7/hausp regulates hedgehog signaling. Dev Cell, 34(1): 58–72. https://doi.org/10.1016/j.devcel.2015.05.016 

Wilson P, Abdelmoti L, Norcross R, et al., 2021, The role of USP7 in the Shoc2-ERK1/2 signaling axis and noonan-like syndrome with loose anagen hair. J Cell Sci, 134(21): jcs258922. https://doi.org/10.1242/jcs.258922

von Locquenghien M, Rozalén C, Celià-Terrassa T, 2021, Interferons in cancer immunoediting: Sculpting metastasis and immunotherapy response. J Clin Invest, 131(1): e143296. https://doi.org/10.1172/JCI143296

Takaoka A, Yanai H, 2006, Interferon signalling network in innate defence. Cell Microbiol, 8(6): 907–922. https://doi.org/10.1111/j.1462-5822.2006.00716.x

Chu TS, 1974, Interferon and its clinical application. Zhonghua Yi Xue Za Zhi, 9: 576–579. 

Xu LG, Wang YY, Han KJ, et al., 2005, VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell, 19(6): 727–740. https://doi.org/10.1016/j.molcel.2005.08.014

Fitzgerald KA, McWhirter SM, Faia KL, et al., 2003, IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol, 4(5): 491–496. https://doi.org/10.1038/ni921

Yu CF, Peng WM, Schlee M, et al., 2018, SOCS1 and SOCS3 target IRF7 degradation to suppress TLR7-mediated Type I IFN production of human plasmacytoid dendritic cells. J Immunol, 200(12): 4024–4035. https://doi.org/10.4049/jimmunol.1700510

Blumer T, Coto-Llerena M, Duong FHT, et al., 2017, SOCS1 is an inducible negative regulator of interferon λ (IFN- λ)-induced gene expression in vivo. J Biol Chem, 292(43): 17928–17938. https://doi.org/10.1074/jbc.M117.788877 

Ding L, Li J, Li W, et al., 2018, p53 mediated IFN-β signaling to affect viral replication upon TGEV infection. Vet Microbiol, 227: 61–68. https://doi.org/10.1016/j.vetmic.2018.10.025 

Lee HR, Toth Z, Shin YC, et al., 2009, Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J Virol, 83(13): 6739–6747. https://doi.org/10.1128/JVI.02353-08

Li X, Wang T, Tao Y, et al., 2022, Inhibition of USP7 suppresses advanced glycation end-induced cell cycle arrest and senescence of human umbilical vein endothelial cells through ubiquitination of p53. Acta Biochim Biophys Sin (Shanghai), 54(3): 311–320. https://doi.org/10.3724/abbs.2022003

Mandras SA, Mehta HS, Vaidya A, 2020, Pulmonary hypertension: A brief guide for clinicians. Mayo Clin Proc, 95(9): 1978–1988. https://doi.org/10.1016/j.mayocp.2020.04.039 

Poch D, Mandel J, 2021, Pulmonary hypertension. Ann Intern Med, 174(4): ITC49–ITC64. https://doi.org/10.7326/AITC202104200

Zhu Y, Zhang Q, Yan X, et al., 2021, Ubiquitin-specific protease 7 mediates platelet-derived growth factor-induced pulmonary arterial smooth muscle cells proliferation. Pulm Circ, 11(4): 20458940211046131. https://doi.org/10.1177/20458940211046131

Uhlen M, Zhang C, Lee S, et al., 2017, A pathology atlas of the human cancer transcriptome. Science, 357(6352): eaan2507. https://doi.org/10.1126/science.aan2507 

Davoodpour P, Landström M, Welsh M, 2007, Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein. BMC Cancer, 7: 161.

Qu CF, Chen TY, Wang YT, et al., 2018, Primary prevention model of liver cancer in rural China. Zhonghua Zhong Liu Za Zhi, 40(7): 481–489. https://doi.org/10.3760/cma.j.issn.0253-3766.2018.07.001

Dong L, Yu L, Bai C, et al., 2018, USP27-mediated cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis. Oncogene, 37(20): 2702–2713. https://doi.org/10.1038/s41388-018-0137-z

Zhang W, Zhang J, Xu C, et al., 2020, Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell Int, 20: 28. https://doi.org/10.1186/s12935-020-1109-2

Cai JB, Shi GM, Dong ZR, et al., 2015, Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology, 61(5): 1603–1614. https://doi.org/10.1002/hep.27682

Chauhan D, Tian Z, Nicholson B, et al., 2012, A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell, 22(3): 345–358.

Colland F, Formstecher E, Jacq X, et al., 2009, Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Mol Cancer Ther, 8(8): 2286–2295. https://doi.org/10.1158/1535-7163.MCT-09-0097

Nicholson B, Suresh Kumar KG, 2011, The multifaceted roles of USP7: New therapeutic opportunities. Cell Biochem Biophys, 60(1–2): 61–68. 

Reverdy C, Conrath S, Lopez R, et al., 2012, Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol, 19(4): 467–477. https://doi.org/10.1016/j.chembiol.2012.02.007

Altun M, Kramer HB, Willems LI, et al., 2011, Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes. Chem Biol, 18(11): 1401–1412. https://doi.org/10.1016/j.chembiol.2011.08.018 

Fan YH, Cheng J, Vasudevan SA, et al., 2013, USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53- mediated apoptosis. Cell Death Dis, 4(10): e867. https://doi.org/10.1038/cddis.2013.400

Shin SB, Kim CH, Jang HR, 2020, Combination of inhibitors of USP7 and PLK1 has a strong synergism against paclitaxel resistance. Int J Mol Sci, 21(22): 8629. https://doi.org/10.3390/ijms21228629

Fu C, Zhu X, Xu P, et al., 2019, Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy. Oncol Targets Ther, 12: 609–617. https://doi.org/10.2147/OTT.S182806

Yang L, Cao N, Miao Y, et al., 2021, Morin acts as a USP7 inhibitor to hold back the migration of rheumatoid arthritis fibroblast-like synoviocytes in a “Prickle1-mTORC2” dependent manner. Mol Nutr Food Res, 65(19): e2100367. https://doi.org/10.1002/mnfr.202100367

Yu Z, Wei X, Liu L, et al., 2022, Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma. EBioMedicine, 78: 103950. https://doi.org/10.1016/j.ebiom.2022.103950

Hu T, Zhang J, Sha B, et al., 2019, Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis. Mol Carcinog, 58(1): 42–54. https://doi.org/10.1002/mc.22905

Becker K, Marchenko ND, Palacios G, et al., 2008, A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle, 7(9): 1205–1213. https://doi.org/10.4161/cc.7.9.5756